Mirelle (Ethinylestradiol, Gestodene | Lactose Monohydrate)

Ethinylestradiol / Gestodene, the active ingredient in Mirelle, is a combined oral contraceptive presented as a combined oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Mirelle as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirelle is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle to prevent pregnancy. - Prevention of pregnancy: provides reliable contraception for women of child‑bearing potential. - Cycle regulation: helps establish regular menstrual bleeding patterns. - Acne improvement: may reduce androgen‑related acne in some users.

Mirelle may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight gain: modest fluid retention. - Mood changes: irritability or emotional lability.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Stroke: cerebrovascular accident, especially in high‑risk women. - Myocardial infarction: heart attack in susceptible individuals. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hepatic adenoma: benign liver tumor. - Hypertension: new‑onset or worsening high blood pressure.

Before prescribing Mirelle, clinicians should assess individual risk factors and contraindications. - Pregnancy contraindication: must not be used during pregnancy. - Smoking restriction: avoid in women over 35 who smoke. - Thromboembolic history: contraindicated in patients with prior clotting events. - Liver disease: use with caution in hepatic impairment. - Hypertension: monitor blood pressure regularly. - Store at below 25°C: keep in the original pack, protect from moisture.

Mirelle can interact with several medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampicin: decreases plasma levels of both hormones. - St. John's Wort: may lead to contraceptive failure.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may increase hormone concentrations. - Certain antidepressants (e.g., SSRIs): may affect bleeding patterns. - Diuretics and antihypertensives: monitor blood pressure and electrolyte balance.